PVLA

Palvella Therapeutics, Inc. Common Stock
PVLA

Overview Fund Activity

27 hedge funds and large institutions have $50.4M invested in Palvella Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Holders
27
Holders Change
+3
Holders Change %
+12.5%
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
7
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$661K
2
SFM
2
Sphera Funds Management
Israel
$2.6M
3
EI
3
EAM Investors
California
$475K
4
BlackRock
4
BlackRock
New York
$233K
5
LOAMU
5
Lombard Odier Asset Management (USA)
New York
$6.5M

Top Sellers

1
SM
1
Sabby Management
Florida
$0
2
TCM
2
Tekla Capital Management
Massachusetts
$10.2M
3
DCM
3
DAFNA Capital Management
California
$139K
4
OC
4
Oppenheimer & Co
New York
$0
5
VKH
5
Virtu KCG Holdings
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$1K +$1K +3 New
Walleye Trading
27
Walleye Trading
New York
$37 +$32 +153 +665%
SM
28
Sabby Management
Florida
– -$1.81M -16,200 Closed
OC
29
Oppenheimer & Co
New York
– -$23K -206 Closed
VKH
30
Virtu KCG Holdings
New York
– -$20K -180 Closed
1
2